In the latest trading session,, 3.33 million Bone Biologics Corp (NASDAQ:BBLG) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $0.90 changing hands around $0.16 or 21.18% at last look, the market valuation stands at $2.94M. BBLG’s current price is a discount, trading about -372.22% off its 52-week high of $4.25. The share price had its 52-week low at $0.57, which suggests the last value was 36.67% up since then. When we look at Bone Biologics Corp’s average trading volume, we note the 10-day average is 69380.0 shares, with the 3-month average coming to 84.13K.
Bone Biologics Corp (NASDAQ:BBLG) trade information
Instantly BBLG is in green as seen in intraday trades today. With action 16.12%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -4.30%, with the 5-day performance at 16.12% in the green. However, in the 30-day time frame, Bone Biologics Corp (NASDAQ:BBLG) is 30.42% up. Looking at the short shares, we see there were 72405.0 shares sold at short interest cover period of 1.54 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 55.67%.
BBLG Dividends
Bone Biologics Corp is expected to release its next quarterly earnings report on 2025-May-11.
Bone Biologics Corp (NASDAQ:BBLG)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.12% of Bone Biologics Corp shares while 1.10% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.10%. There are 1.10% institutions holding the Bone Biologics Corp stock share, with UBS GROUP AG the top institutional holder. As of 2024-06-30, the company held 5.1% of the shares, roughly 33707.0 BBLG shares worth $41123.0.
HRT FINANCIAL LP holds the second largest percentage of outstanding shares, with 2.6507% or 17519.0 shares worth $21000.0 as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund . With 16.52 shares estimated at $13107.0 under it, the former controlled 0.50% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Total Market Index Fund held about 0.12% of the shares, roughly 3.94 shares worth around $3123.0.
